Sacituzumab Govitecan Plus Pembrolizumab for Patients With Metastatic Urothelial Cancer Who Progressed After Platinum-Based Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3
J. Clin. Oncol 2024 Jan 23;[EPub Ahead of Print], P Grivas, D Pouessel, CH Park, P Barthelemy, M Bupathi, DP Petrylak, N Agarwal, S Gupta, A Fléchon, C Ramamurthy, NB Davis, A Recio-Boiles, CN Sternberg, A Bhatia, C Pichardo, M Sierecki, J Tonelli, H Zhou, ST Tagawa, Y LoriotFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.